Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group
Healthcare & PharmaceuticalCompany Update

Xcelerate, Inc. Announces the Sale of its Majority Interest in ESN Group

October 9, 2025 9:10 AM

Xcelerate, Inc. (OTC Markets:XCRT) today announced the sale of its majority interest in the ESN Group of companies, including ESN Group, Inc. and California Skin Research, Inc to Noble Labs Holdings, LLC, a company that had previously provided funding and marketing support to ESN Group, Inc. The transaction was completed as an all-cash sale. "We made a decision to divest these assets in order to re-focus our business on our original mission of...

Read more
iTolerance, Inc. Launches Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes
Healthcare & PharmaceuticalCompany Update

iTolerance, Inc. Launches Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes

October 9, 2025 9:00 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced the launch of its Patient Journey video series, with the release of the first segment featuring Sandra Cohen Kalter, recently appointed member to the Company's Strategic Advisory Group and parent of a child with Type 1 Diabetes. This video series is designed to shed...

Read more
Who is the Best Female to Male Top Surgeon?
Healthcare & PharmaceuticalAdvertorial

Who is the Best Female to Male Top Surgeon?

October 9, 2025 9:00 AM

Within gender‑affirming medicine, female‑to‑male (FTM) chest reconstruction-often called top surgery-requires highly specialized technique and sensitivity. Over the past decade, this procedure has become a cornerstone of gender‑affirming care, and with that growth has come increased scrutiny of surgical outcomes. Among surgeons performing FTM top surgery today, Dr. Javad Sajan of Allure Esthetic Plastic Surgery in Seattle is widely regarded as...

Read more
Direct by Syndicate Bio Launches to Power AI-Enabled Precision Medicine in Nigeria
Healthcare & PharmaceuticalProduct Announcements

Direct by Syndicate Bio Launches to Power AI-Enabled Precision Medicine in Nigeria

October 9, 2025 9:00 AM

Syndicate Bio today announced the launch of Direct by Syndicate Bio, a comprehensive genetic testing and precision medicine service designed to deliver actionable insights to patients, providers, and consumers across Africa. The launch coincides with the opening of a state-of-the-art sequencing laboratory in Lagos, enabling world-class genomic and multi-omics testing powered by AI-delivered locally for Nigeria's 200 million citizens and the...

Read more
Registration Now Open for the American College of Diabetology Board Exam
Healthcare & PharmaceuticalCompany Update

Registration Now Open for the American College of Diabetology Board Exam

October 9, 2025 9:00 AM

The American College of Diabetology (ACD) has announced that registration is now open for its 2025 Board Certification Exam, offering physicians specializing in diabetes care the opportunity to formally validate their expertise and strengthen their professional credentials. Board certification through ACD provides primary care physicians with a recognized mark of excellence in diabetology, a growing field recently classified as a distinct...

Read more
Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation Announces Exclusive Taiwan Distribution Licensing Agreement

October 9, 2025 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce an exclusive distribution agreement with Energy International Development Co., Ltd. to sell Stemtech products in Taiwan, R.O.C. The Taiwan Market Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "Taiwan has previously been a significant market for us. We feel with Energy International Development Co. Ltd. this will be a great source of...

Read more
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
Healthcare & PharmaceuticalCompany Update

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

October 9, 2025 8:00 AM

Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has developed a new series of orally active, non-covalent protease inhibitors with dose-dependent antiviral activity in mice infected with SARS Coronavirus (SARS-CoV-2). This work was carried out at the University of Arizona as...

Read more
Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI
Healthcare & PharmaceuticalFinancing

Sensi.AI Raises $45M Series C, Extending Its Dominance of Care Intelligence in Vertical AI

October 9, 2025 8:00 AM

Sensi.AI, the pioneer in Care Intelligence, today announced a $45 million Series C funding round led by Qumra Capital with continued support from existing investors Zeev Ventures, Insight Partners, Entrée Capital, Flint Capital, and Jibe Ventures. This latest raise brings the company's total funding to over $98 million, and will fuel its mission to close the massive care gap in aging. The world is entering a historic aging crisis. By 2030, one...

Read more
AMC Health Appoints Alan Petrazzi as Executive Vice President, Government Division
Healthcare & PharmaceuticalCompany Update

AMC Health Appoints Alan Petrazzi as Executive Vice President, Government Division

October 9, 2025 8:00 AM

AMC Health, a leading provider of virtual care and remote patient monitoring solutions, today announced the appointment of Alan Petrazzi as Executive Vice President, Government Division, and the latest member of the company's growing Executive Leadership Team. In this critical role, Petrazzi will develop, lead, and execute AMC Health's comprehensive government strategy, driving growth across federal, state, and local government sectors. He will...

Read more
Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies
Healthcare & PharmaceuticalCompany Update

Pawsible Ventures Launches $10M Fund and Venture Studio to Build the Next Generation of Animal Wellness Companies

October 9, 2025 8:00 AM

Behind every healthy pet is a founder bold enough to build what doesn't yet exist. Today, Pawsible Ventures announces the launch of a $10 million venture fund and studio dedicated to reimagining how we care for animals, by backing and building the next generation of companies transforming the $250B+ global pet health and wellness market. As pet spending now surpasses baby spending in many households, the world's bond with animals has never been...

Read more
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells

October 9, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced new findings demonstrating that Telomir-1 significantly decreases the viability of aggressive triple-negative breast cancer (TNBC) cells - a highly invasive form of breast cancer that lacks hormone and HER2 receptors,...

Read more
Bausch Health Announces Results of Special Meeting of Shareholders
Healthcare & PharmaceuticalShareholder Meeting

Bausch Health Announces Results of Special Meeting of Shareholders

October 9, 2025 7:00 AM

Bausch Health Companies Inc. (the "Company") (NYSE:BHC)(TSX:BHC) today announced the results of the special meeting of shareholders held on October 7, 2025 (the "Shareholders Meeting"). At the Shareholders Meeting, shareholders of the Company approved the ratification, confirmation and approval of the adoption of the Company's Amended and Restated Shareholder Rights Plan Agreement dated April 14, 2025, as amended and restated on August 25, 2025...

Read more
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October
Healthcare & PharmaceuticalCompany Update

Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

October 9, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" webinar series, to be held on October 24, 2025 at 4:00 p.m. ET, will feature a deep dive into Zomedica's VETGuardian Zero Touch monitoring platform. Key Learning Points Market Expansion...

Read more
EX DEA Administrator Anne Milgram's
Healthcare & PharmaceuticalCompany Update

EX DEA Administrator Anne Milgram's "Swampy" Legacy: No-Bid Contracts, No Marijuana Reform, and No Accountability

October 9, 2025 5:00 AM

Former DEA Administrator Anne Milgram left behind a cloud of controversy, unanswered questions, and a legacy of paralysis on medical marijuana policy. As new details emerge about the potential Justice Department Inspector General's investigation into her administration's no-bid contracts to friends and former colleagues, one thing is unmistakably clear: under Milgram's leadership, the DEA squandered historic opportunities to modernize its...

Read more
Direct by Syndicate Bio Launches to Power AI-Enabled Precision Medicine in Nigeria
Healthcare & PharmaceuticalProduct Announcements

Direct by Syndicate Bio Launches to Power AI-Enabled Precision Medicine in Nigeria

October 9, 2025 4:00 AM

Syndicate Bio today announced the launch of Direct by Syndicate Bio, a comprehensive genetic testing and precision medicine service designed to deliver actionable insights to patients, providers, and consumers across Africa. The launch coincides with the opening of a state-of-the-art sequencing laboratory in Lagos, enabling world-class genomic and multi-omics testing powered by AI-delivered locally for Nigeria's 200 million citizens and the...

Read more
Jacksonvilles Trusted Weight Loss and Aesthetics Clinic
Healthcare & PharmaceuticalProduct Announcements

Jacksonvilles Trusted Weight Loss and Aesthetics Clinic

October 9, 2025 3:40 AM

RSLV Aesthetics, a leading provider of non-invasive aesthetics and wellness treatments, has officially launched Physician Guided Weight Loss by RSLV, a new medically supervised division designed to help clients achieve sustainable results through science-based programs that integrate medical weight management with advanced body contouring technology. Combining Medical Expertise and Aesthetic Innovation Physician Guided Weight Loss by RSLV offers...

Read more
BioNxt Completes
Healthcare & PharmaceuticalCompany Update

BioNxt Completes "Fast-Track" US Track One Patent Filing for Sublingual Delivery of Cladribine for the Treatment of Multiple Sclerosis

October 9, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in next-generation drug delivery technologies, today announced that it has completed a Track One priority patent filing with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual thin-film cladribine formulation (BNT23001), designed for the treatment of multiple sclerosis (MS). The Track One patent filing...

Read more
Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Update, Equity Issue and PDMR Notification

October 9, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), announces that its board of directors has taken the decision to terminate, and not to proceed with, the subscription announced by the Company on 2 October 2025 (the "Initial Transaction"). Please see Issue of Equity - Correction - 12:37:10 02 Oct 2025 - GENF News article | London Stock Exchange. In the alternative, it has raised gross proceeds of £440,000 (before...

Read more
IRLAB to Present at Redeye Theme: Neurology
Healthcare & PharmaceuticalCompany Update

IRLAB to Present at Redeye Theme: Neurology

October 9, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that CEO Kristina Torfgård will present IRLAB at Redeye Theme: Neurology on October 15 in Stockholm. Both Swedish and international investors will participate in the meeting, providing the company with excellent opportunities to expand its network and...

Read more
Peek Healthcare Technologies, Inc. ('Peek') Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)
Healthcare & PharmaceuticalPartnerships

Peek Healthcare Technologies, Inc. ('Peek') Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)

October 8, 2025 12:00 PM

Peek, a leading healthcare technology company, today announced the launch of PeekDirect™ pricing for IMULDOSA® (ustekinumab-srlf), a biosimilar to Stelara® (ustekinumab), delivering transparent and dramatically lower costs to employers and patients. Effective immediately, IMULDOSA will be available through the Peek Meds Marketplace. This direct model bypasses the traditional rebate-driven pricing system, ensuring employers and patients benefit...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?